Viewing Study NCT03562832


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-01-23 @ 1:39 PM
Study NCT ID: NCT03562832
Status: COMPLETED
Last Update Posted: 2025-01-23
First Post: 2018-04-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
Sponsor:
Organization: